Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01576432
Other study ID # 260 271110
Secondary ID
Status Terminated
Phase N/A
First received April 2, 2012
Last updated April 10, 2012
Start date January 2011
Est. completion date April 2012

Study information

Verified date April 2012
Source Puerta de Hierro University Hospital
Contact n/a
Is FDA regulated No
Health authority Spain: Ethics Committee
Study type Interventional

Clinical Trial Summary

Objective

To investigate the analgesic effect (measured with NIPS) of breastfeeding in addition to skin-to-skin contact versus other methods of non-pharmacological analgesia during blood sampling through heel lance in healthy term neonates. The influences of non-pharmacological methods on crying time, percentage of crying while sampling, heart rate, number of attempts and duration of sampling were studied.

Methods

Randomised controlled trial performed on 136 healthy term newborns in the maternity ward of a tertiary hospital. The inclusion criteria were: healthy term neonates, wish to breastfeed and absence of feeding during the previous 60 minutes. Neonates were randomly assigned to four groups: group 1, breastfed with skin-to-skin contact ; group 2, oral sucrose with skin-to-skin contact ; group 3, skin-to-skin contact ; or group 4, receiving oral sucrose Data for the primary objective was analysed per intention to treat. This study was approved by local ethical committee.


Description:

Healthy term newborns commonly undergo painful procedures even if they do not need intensive care. Heel lance for neonatal screening is the most frequent standardized painful procedure performed in these newborns. Until recently, analgesics were rarely administered to neonates because it was believed that they were less sensitive to pain than more mature infants but current studies suggest that newborns are able to perceive pain. Regardless of the available evidence, appropriate systematic analgesia in common painful procedures in neonates is far from adequate.

Painful stimuli in neonates may have short-term physiologic (increase in intracranial pressure, increase in heart rate or decrease in oxygen saturation) and behavioural consequences (cry, eye squeeze); as well as long-term consequences (altered of pain response in later infancy). Different non-pharmacological methods of analgesia, such as sucrose, skin-to-skin contact (SSC), breastfeeding(BF) or music10, have been used to reduce pain in neonates undergoing venipuncture or heel lancing, and different physiologic pathways to explain the underlying mechanism have been proposed.

A variety of valid and reliable pain assessment instruments have been developed over the past decades. Yet, behavioural pain assessment remains challenging and controversial due to the lack of a gold standard for neonatal pain expression. The Neonatal Infant Pain Scale (NIPS) and the Premature Infant Pain Profile (PIPP) were selected by an international consensus neonatal pain group for acute procedural pain in neonates.

Our main objective was to investigate the analgesic effect (measured with NIPS) of breastfeeding in addition to SSC versus other methods of non-pharmacological analgesia during blood sampling through heel lance in healthy term neonates. Furthermore, the influences of non-pharmacological methods on crying time, percentage of crying while sampling, heart rate, number of attempts and time of sampling were studied.

METHODS

Protocol

This randomised controlled trial was performed on 136 healthy term newborns in the maternity ward of a tertiary hospital. The inclusion criteria were as follows: healthy term neonates (37-416 weeks of gestation) confirmed through a routine physical exam during the first 24h of life, wish to breastfeed and absence of feeding during the previous 60 minutes. Exclusion criteria were as follows: maternal use of opioids, birth in general anesthesia, artificial feeding, previous capillar or venous sampling, and previous admission to the neonatal unit.

Written informed consent was asked to parents during consultation. Study protocol and informed-consent forms were approved by the local ethics committee.

Intervention

Participating neonates were randomly assigned to four groups: group 1, breastfed with SSC (n=35); group 2, receiving oral sucrose with SSC (n=35); group 3, being held in SSC (n=33); or group 4, receiving oral sucrose (n=33). Randomisation was by closed envelopes and nurses and parents were masked to the randomization group but not blinded to the treatment assignment. In group 1 (BF+SSC), neonates dressed with a diaper were held in prone, in SSC with the mother; BF was started at least 5 minutes before heel lance and maintained during sampling. In group 2 (sucrose + SSC), neonates were held in prone between the mothers' breast at least 5 minutes before sampling and 2 ml 24% sucrose was given with a sterile syringe in the mouth 2 minutes before heel lance. In group 3 (SSC), neonates were held between the mother's breast as in group 2, but no sucrose was given. In group 4 (Sucrose), 2 ml 24% sucrose was administered through a sterile syringe in the mouth 2 minutes before heel lance to neonates laid on supine on a cot; the procedure was done in the presence of the mother. Mothers were allowed to speak or touch their babies in all the groups. The standardized procedure of heel prick in our hospital is such as described in group 4.

Throughout the duration of the test, babies were continuously recorded with a video camera at least 2 minutes before sampling and 2 minutes after the procedure. The heel was warmed up by a glove with lukewarm water at least 2 minutes before the sample. Heel lance was made with an automated piercing device for routine neonatal screening for congenital disorders at 48 hours of life. Heart rate was monitored by a pulse oximeter (Radical MasimoSet Datascope, Masimo Corporation, Irvine, CA) set on the infant's hand or foot. Hear rate was measured continuously but special attention was given to three time points: t0 (2 minutes before sampling); t1 (the highest value of the first 10 seconds after heel prick); and t2 (2 minutes after the procedure).

Blood sampling was performed through a standardized procedure by five experienced nurses, who obtained 5 dried spots of blood collected on a filter paper card. If the sample was not enough to complete all of the dried spots on the filter card, a new heel lance was practiced in few seconds. In this case, neonates were assessed for NIPS measure only after the first heel lance; secondary outcomes were evaluated during the whole sampling. Crying time was defined as the duration of crying while sampling. Percentage of crying was defined as the ratio between crying time while sampling and time of the procedure.

Pain scale

The NIPS scale is a validated 6-indicator scale for the assessment of acute pain in neonates11,13. It measure movement of arms and legs, breathing patterns, cry, facial expression and state of arousal. Score ranges from 0 (no pain) to 7 (severe pain). NIPS score <4 means no pain-mild pain. NIPS score ≥4 means moderate-severe pain. NIPS score was measured at three time points: NIPS0 (2 minutes before sampling); NIPS1 (the highest value of the scale in the first 10 seconds after heel prick); and NIPS2 (2 minutes after the procedure). NIPS2 was not recorded if sampling had not finished at this time point. This took place in one newborn (2,8%) of group 1, five (14,2%), six (18.1%), and five (15.1%) of group 2, 3 and 4 respectively. NIPS was measured by three researchers who watched the videos: one expert neonatologist (Observer 1) and two young paediatricians (Observers 2 and 3). Coincidence was 90.8% (95% CI 87.8-93.8) between observers 1 and 2; 75% (70.5-79.5) between observers 1 and 3; and 78.7% (74.7-82.9) between observers 2 and 3. Consequently, only data of the expert neonatologist is shown.

Statistical Analysis

A sample size of 67 infants in each group was calculated to achieve a power of 80% with an α of 0.05 to detect a 0.5-point difference in the NIPS score (assuming SD=1). We decided to make a mid-point analysis when half of the neonates were recruited in order to detect if any of the analgesic methods was better than the standard procedure, and thus modify our clinical practice.

Results were expressed as mean ± standard deviation (SD). Categorical variables were analysed with the χ2 test and the Fisher test. We compared mean between groups with the t-test, ANOVA test and Bonferroni test. We used Mann-Whitney U test, non-parametric ANOVA and Kruskal-Wallis to compare median between groups. The SPSS v.14.0 software package was used to perform all statistical analysis (SPSS Inc. IL, USA). A p-value of 0.05 was considered a statistically significant level of difference. The analysis of the main objective was conducted on an intention-to-treat. Secondary objectives were analysed according to protocol.


Recruitment information / eligibility

Status Terminated
Enrollment 136
Est. completion date April 2012
Est. primary completion date February 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 37 Weeks to 41 Weeks
Eligibility Inclusion Criteria:

- Healthy term neonates (37-41+6 weeks of gestation) confirmed through a routine physical exam during the first 24h of life

- Wish to breastfeed

- Absence of feeding during the previous 60 minutes.

Exclusion Criteria:

- Maternal use of opioids.

- Birth in general anesthesia.

- Artificial feeding.

- Previous capillar or venous sampling.

- Previous admission to the neonatal unit.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Caregiver), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Assess pain with the NIPS score
In group 1 (BF+SSC), neonates dressed with a diaper were held in prone, in SSC with the mother; BF was started at least 5 minutes before heel lance and maintained during sampling. In group 2 (sucrose + SSC), neonates were held in prone between the mothers' breast at least 5 minutes before sampling and 2 ml 24% sucrose was given with a sterile syringe in the mouth 2 minutes before heel lance. In group 3 (SSC), neonates were held between the mother's breast as in group 2, but no sucrose was given. In group 4 (Sucrose), 2 ml 24% sucrose was administered through a sterile syringe in the mouth 2 minutes before heel lance to neonates laid on supine on a cot; the procedure was done in the presence of the mother. Mothers were allowed to speak or touch their babies in all the groups.

Locations

Country Name City State
Spain Hospital Universitario Puerta de Hierro-Majadahonda Madrid

Sponsors (1)

Lead Sponsor Collaborator
Puerta de Hierro University Hospital

Country where clinical trial is conducted

Spain, 

References & Publications (30)

Anand KJ. Clinical importance of pain and stress in preterm neonates. Biol Neonate. 1998;73(1):1-9. Review. — View Citation

Anand KJ; International Evidence-Based Group for Neonatal Pain. Consensus statement for the prevention and management of pain in the newborn. Arch Pediatr Adolesc Med. 2001 Feb;155(2):173-80. Review. — View Citation

Bellieni CV, Bagnoli F, Perrone S, Nenci A, Cordelli DM, Fusi M, Ceccarelli S, Buonocore G. Effect of multisensory stimulation on analgesia in term neonates: a randomized controlled trial. Pediatr Res. 2002 Apr;51(4):460-3. — View Citation

Bilgen H, Ozek E, Cebeci D, Ors R. Comparison of sucrose, expressed breast milk, and breast-feeding on the neonatal response to heel prick. J Pain. 2001 Oct;2(5):301-5. Retraction in: J Pain. 2003 Sep;4(7):415. — View Citation

Blass EM. Behavioral and physiological consequences of suckling in rat and human newborns. Acta Paediatr Suppl. 1994 Jun;397:71-6. Review. — View Citation

Carbajal R, Veerapen S, Couderc S, Jugie M, Ville Y. Analgesic effect of breast feeding in term neonates: randomised controlled trial. BMJ. 2003 Jan 4;326(7379):13. — View Citation

Castral TC, Warnock F, Leite AM, Haas VJ, Scochi CG. The effects of skin-to-skin contact during acute pain in preterm newborns. Eur J Pain. 2008 May;12(4):464-71. Epub 2007 Sep 14. — View Citation

Codipietro L, Ceccarelli M, Ponzone A. Breastfeeding or oral sucrose solution in term neonates receiving heel lance: a randomized, controlled trial. Pediatrics. 2008 Sep;122(3):e716-21. doi: 10.1542/peds.2008-0221. — View Citation

Gibbins S, Stevens B. Mechanisms of sucrose and non-nutritive sucking in procedural pain management in infants. Pain Res Manag. 2001 Spring;6(1):21-8. Review. — View Citation

Gradin M, Schollin J. The role of endogenous opioids in mediating pain reduction by orally administered glucose among newborns. Pediatrics. 2005 Apr;115(4):1004-7. — View Citation

Gray L, Miller LW, Philipp BL, Blass EM. Breastfeeding is analgesic in healthy newborns. Pediatrics. 2002 Apr;109(4):590-3. — View Citation

Gray L, Watt L, Blass EM. Skin-to-skin contact is analgesic in healthy newborns. Pediatrics. 2000 Jan;105(1):e14. — View Citation

Grunau RE, Holsti L, Peters JW. Long-term consequences of pain in human neonates. Semin Fetal Neonatal Med. 2006 Aug;11(4):268-75. Epub 2006 Apr 24. Review. — View Citation

Hartling L, Shaik MS, Tjosvold L, Leicht R, Liang Y, Kumar M. Music for medical indications in the neonatal period: a systematic review of randomised controlled trials. Arch Dis Child Fetal Neonatal Ed. 2009 Sep;94(5):F349-54. doi: 10.1136/adc.2008.148411. Epub 2009 May 28. Review. — View Citation

Johnston CC, Stevens B, Pinelli J, Gibbins S, Filion F, Jack A, Steele S, Boyer K, Veilleux A. Kangaroo care is effective in diminishing pain response in preterm neonates. Arch Pediatr Adolesc Med. 2003 Nov;157(11):1084-8. — View Citation

Lawrence J, Alcock D, McGrath P, Kay J, MacMurray SB, Dulberg C. The development of a tool to assess neonatal pain. Neonatal Netw. 1993 Sep;12(6):59-66. — View Citation

Leslie A, Marlow N. Non-pharmacological pain relief. Semin Fetal Neonatal Med. 2006 Aug;11(4):246-50. Epub 2006 Apr 24. Review. — View Citation

Lindh V, Wiklund U, Håkansson S. Heel lancing in term new-born infants: an evaluation of pain by frequency domain analysis of heart rate variability. Pain. 1999 Mar;80(1-2):143-8. — View Citation

Ludington-Hoe SM, Swinth JY. Developmental aspects of kangaroo care. J Obstet Gynecol Neonatal Nurs. 1996 Oct;25(8):691-703. Review. — View Citation

Mainous RO, Looney S. A pilot study of changes in cerebral blood flow velocity, resistance, and vital signs following a painful stimulus in the premature infant. Adv Neonatal Care. 2007 Apr;7(2):88-104. — View Citation

Marín Gabriel MA, López Escobar A, Galán Redondo M, Fernández Moreno I, del Cerro García R, Llana Martín I, de la Cruz Bértolo J, Lora Pablos D. [Evaluation of pain in a neonatal intensive care unit during endocrine-metabolic tests]. An Pediatr (Barc). 2008 Oct;69(4):316-21. Spanish. Erratum in: An Pediatr (Barc). 2010 Mar;72(3):236. Fernández Bule, I [corrected to Fernández Moreno, I]. — View Citation

Okan F, Ozdil A, Bulbul A, Yapici Z, Nuhoglu A. Analgesic effects of skin-to-skin contact and breastfeeding in procedural pain in healthy term neonates. Ann Trop Paediatr. 2010;30(2):119-28. doi: 10.1179/146532810X12703902516121. — View Citation

Overgaard C, Knudsen A. Pain-relieving effect of sucrose in newborns during heel prick. Biol Neonate. 1999 May;75(5):279-84. — View Citation

Perapoch López J, Pallás Alonso CR, Linde Sillo MA, Moral Pumarega MT, Benito Castro F, López Maestro M, Caserío Carbonero S, de la Cruz Bértolo J. [Developmental centered care. Evaluation of Spanish neonatal units]. An Pediatr (Barc). 2006 Feb;64(2):132-9. Spanish. — View Citation

Porter FL, Wolf CM, Gold J, Lotsoff D, Miller JP. Pain and pain management in newborn infants: a survey of physicians and nurses. Pediatrics. 1997 Oct;100(4):626-32. — View Citation

Slater R, Cornelissen L, Fabrizi L, Patten D, Yoxen J, Worley A, Boyd S, Meek J, Fitzgerald M. Oral sucrose as an analgesic drug for procedural pain in newborn infants: a randomised controlled trial. Lancet. 2010 Oct 9;376(9748):1225-32. doi: 10.1016/S0140-6736(10)61303-7. — View Citation

Stevens B, Johnston C, Petryshen P, Taddio A. Premature Infant Pain Profile: development and initial validation. Clin J Pain. 1996 Mar;12(1):13-22. — View Citation

Upadhyay A, Aggarwal R, Narayan S, Joshi M, Paul VK, Deorari AK. Analgesic effect of expressed breast milk in procedural pain in term neonates: a randomized, placebo-controlled, double-blind trial. Acta Paediatr. 2004 Apr;93(4):518-22. — View Citation

Weller A, Blass EM. Behavioral evidence for cholecystokinin-opiate interactions in neonatal rats. Am J Physiol. 1988 Dec;255(6 Pt 2):R901-7. — View Citation

Weller A, Feldman R. Emotion regulation and touch in infants: the role of cholecystokinin and opioids. Peptides. 2003 May;24(5):779-88. Review. — View Citation

* Note: There are 30 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary NIPS score during heel prick in healthy term neonates The NIPS scale is a validated 6-indicator scale for the assessment of acute pain in neonates. Score ranges from 0 (no pain) to 7 (severe pain).
NIPS score was evaluated at three time points (2 minutes before heel prick (NIPS-t0), during heel prick (NIPS-t1) and 2 minutes after heel lance (NIPS-t2))in 4 groups where different methods of non-pharmacological analgesia were applied. Results are shown as mean+-SD.
NIPS score =4 means moderate-severe pain. Thus results are also shown as the % of patients with NIPS score =4 at different time points (t0, t1 and t2)
Midpoint analysis will be conducted when half the patients are recruited (134 subjects), at an estimated time of 12 months. Yes
Secondary Crying time during heel prick in healthy term neonates Crying time (in seconds) in 4 groups where different methods of non-pharmacological analgesia were applied. The timer was started at heel prick and stopped when 5 dried spots of blood were collected on a filter paper card. Results are shown as mean+-SD. Midpoint analysis will be conducted when half the patients are recruited (134 subjects), at an estimated time of 12 months. Yes
Secondary Percentage of crying during heel prick in healthy term neonates Percentage of crying in 4 groups where different methods of non-pharmacological analgesia were applied during heel prick. Percentage of crying was defined as the ratio between crying time while sampling and time of the procedure. Results are shown as mean+-SD. Midpoint analysis will be conducted when half the patients are recruited (134 subjects), at an estimated time of 12 months. Yes
Secondary Heart rate during heel prick in healthy term neonates Heart rate was monitored by a pulse oximeter (Radical MasimoSet Datascope, Masimo Corporation, Irvine, CA) set on the infant's hand or foot. Hear rate was measured continuously but special attention was given to three time points: t0 (2 minutes before sampling); t1 (the highest value of the first 10 seconds after heel prick); and t2 (2 minutes after the procedure). Results are shown as Mean+-SD Midpoint analysis will be conducted when half the patients are recruited (134 subjects), at an estimated time of 12 months. Yes
Secondary Sampling duration during heel prick in healthy term neonates Sampling duration (in seconds) was defined as the time spent to obtained 5 dried spots of blood collected on a filter paper card. Results are shown as mean+-SD. Midpoint analysis will be conducted when half the patients are recruited (134 subjects), at an estimated time of 12 months. Yes
Secondary Number of attempts during heel prick Number of attempts need to obtaine 5 dried spots of blood collected on a filter paper card. Results are shown as % of patients with 1 attempt and % of patients with 2 attempts. Midpoint analysis will be conducted when half the patients are recruited (134 subjects), at an estimated time of 12 months. Yes
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05559255 - Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI N/A
Completed NCT04748367 - Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care N/A
Terminated NCT04356352 - Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain Phase 2/Phase 3
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04466111 - Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05868122 - A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy Phase 3
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Completed NCT03273114 - Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain N/A
Enrolling by invitation NCT06087432 - Is PNF Application Effective on Temporomandibular Dysfunction N/A
Completed NCT05508594 - Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001 Phase 2/Phase 3
Recruiting NCT03646955 - Partial Breast Versus no Irradiation for Women With Early Breast Cancer N/A
Active, not recruiting NCT03472300 - Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
Completed NCT03678168 - A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries N/A
Completed NCT03931772 - Online Automated Self-Hypnosis Program N/A
Completed NCT03286543 - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System N/A
Completed NCT02913027 - Can We Improve the Comfort of Pelvic Exams? N/A
Terminated NCT02181387 - Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor? Phase 4
Recruiting NCT06032559 - Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment Phase 3
Active, not recruiting NCT03613155 - Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care